MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
Mereo BioPharma Group plc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.30−0.00 (-0.30%)
Close on Oct 19, 2026
- Market cap
- $242.76M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Mereo BioPharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 18, 2026 | Aug 19, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 8, 2026 | Apr 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2026 | Mar 27, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2026 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 17, 2026 | Feb 17, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 29, 2025 | Dec 29, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2025 | Jul 10, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 13, 2025 | Apr 8, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 26, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2025 | Mar 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2025 | Jan 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 8, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2024 | Aug 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 14, 2024 | Jun 14, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2024 | Jun 12, 2024 | SEC EDGAR |
| Current report | 8-K | May 23, 2024 | May 23, 2024 | SEC EDGAR |
| Current report | 8-K | May 15, 2024 | May 15, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 15, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 23, 2024 | Apr 24, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2024 | Apr 15, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2024 | Mar 27, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 27, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2024 | Jan 8, 2024 | SEC EDGAR |